Loading clinical trials...
Loading clinical trials...
Evaluation of Safety and Exploratory Efficacy of PSC-01, an Autologous Adipose-derived Stromal Vascular Fraction Cell Therapy Product for the Treatment of Knee Osteoarthritis
Conditions
Interventions
PSC-01
Locations
7
United States
San Diego Orthobiologics Medical Group
Carlsbad, California, United States
Grossmont Orthopedic Medical Group
La Mesa, California, United States
Synergy Orthopedic Specialists Medical Group
San Diego, California, United States
The Orthohealing Center
Santa Monica, California, United States
Cellular Orthopedics
Des Plaines, Illinois, United States
New Jersey Regenerative Institute
Cedar Knolls, New Jersey, United States
Start Date
September 7, 2019
Primary Completion Date
January 1, 2021
Completion Date
January 1, 2021
Last Updated
September 16, 2020
NCT06755697
NCT07225829
NCT07351968
NCT06747494
NCT07036003
NCT06906939
Lead Sponsor
Personalized Stem Cells, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions